Authors
Latest:
Access to PCSK9 Inhibitors Still RestrictedAt the American College of Cardiology Scientific Session, a study of prescriptions for PCSK9 inhibitors confirms what doctors say about trying to get their patients access to the cholesterol drug.
Latest:
A Case for Biosimilar Use: 5 Things You Need to KnowBiosimilars are a potential solution to the ever-growing problem of high specialty drug costs.
Latest:
Introduction: Reducing Our Nation's Health Care CostsA revealing GPhA research report on brand name and generic prescription drug sales demonstrates how much generic medicines have saved consumers, as well as state and federal governments, over the past decade.
Latest:
Attitudes, Barriers, and Perceptions Influence Naloxone Prescribing by PharmacistsEvidence suggests that they are not actively using their prescriptive authority, but a new study aims to identify factors affecting their related behaviors.
Latest:
Cost of PrEP May Inhibit Widespread AdoptionAlthough the use of preexposure prophylaxis against HIV has increased across the United States in recent years, the rise in costs across the health care system has yet to be fully catalogued.
Latest:
Low Reporting of Medicaid Diabetes Quality Measures: Room for Improvement?In a review of publicly reported diabetes quality measures for Medicaid fee-for-service, overall reporting was low and reports of outcomes measures were rarely available.
Latest:
New Ointment Found Effective in Eczema TreatmentImprovements in pruritus were achieved earlier with crisaborole for eczema.
Latest:
The Role of Specialty Drugs in Private Sector Healthcare SpendingThis study characterizes the role of specialty drug utilization in aggregate private sector healthcare spending in the United States from 2000 to 2009.
Latest:
GI Cancers: Neuroendocrine Cancer UpdateClinical trial results show that several new combination therapies offer great promise for the treatment of challenging neuroendocrine tumors in the gastrointestinal area.
Latest:
Behavioral-Based Communication Improves Patient OutcomesNonadherence is linked to poor health outcomes, including a decreased quality-of-life, disease progression, and increased hospitalizations.
Latest:
Improving Transplant Care OutcomesFor transplant patients, the difference between a successful and an unsuccessful outcome can be made by medication adherence.
Latest:
Efficacy of Ezetimibe 2.5 mg With a Novel Tablet-Splitting StrategyThis prospective randomized study suggests that ezetimibe 2.5 mg, delivered as an ezetimibe/simvastatin tablet split into 4 parts, is clinically equivalent to a 10-mg dose.
Latest:
Technology Equals Opportunity: Seize the MomentWhether its robots, microbots, smartphones, or 3-dimensional printing, the potential for technology to impact health care and pharmacy excites and motivates Dan Benamoz, RPh, founder and chief executive officer, Pharmacy Development Services.
Latest:
The Road Less Traveled: Nontraditional Work Arrangements in AcademiaAccording to the 2014 National Pharmacist Workforce Study, approximately 18.7% of women and 16.4% of men actively engaged as pharmacists reported working part-time.
Latest:
Practice-Changing Data Revealed for Premenopausal HR+ Breast CancerFindings presented at 50th Annual Meeting of ASCO show aromatase inhibitor effective for premenopausal women when combined with ovarian function suppression.
Latest:
Optimizing Treatment Regimens for Multiple Sclerosis: The Pharmacist's Role in Advancing Patient CareThis Continuing Education activity is supported by educational grants from Sanofi-Aventis US Genzyme and Novartis Pharmaceuticals Corporation.
Latest:
Detecting Signs of Opioid Abuse and Treating the AddictionKnowing the warning signs and establishing trust are crucial to identifying and treating the opioid abuser.
Latest:
Systemic Therapy Options for Treating HR+/HER2– Metastatic Breast CancerFollowing initial breast cancer diagnosis by mammography, MRI, or ultrasound, treatment is largely based upon the histologic subtype and staging of the tumor(s).
Latest:
Trends in Statin Treatment Costs and Potential Impact of Novel TherapiesGeneric atorvastatin led to an increase in generic dispensing rate and a reduction in the cost of treatment for patients requiring cholesterol-lowering treatment. The upcoming introduction of the PCSK9 inhibitor may change this trend.
Latest:
Fostering Rapid Innovation During a Time of CrisisPromoting an environment that allows for rapid problem-solving and execution under high stress is essential to face problems that are poorly understood and yet require rapid change.
Latest:
Implications of STeP for Improved Diabetes Control: A Payer PerspectiveImplementation of the STeP program across managed care organizations could lead to improved patient outcomes and significant cost savings.
Latest:
Manufacturer Reimbursement Support Programs Raise Legal Questions For Specialty PharmaciesNavigating insurance coverage for specialty drugs has always been a complex and fundamental part of the specialty drug distribution chain.
